Expectations in noninvasive medical imaging for screening and quantifying fatty liver;Qu'attendre de l'imagerie médicale non invasive pour dépister et quantifier la stéatose hépatique?

Gastroenterologie Clinique et Biologique

Volumn 29, Issue 11, 2005, Pages 1133-1135

  Chevallier, Patrick ^a  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC IMAGING; EDITORIAL; FATTY LIVER; HUMAN; LIVER BIOPSY; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE; RADIODENSITOMETRY;

EID: 30044441742     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0399-8320(05)82177-3     Document Type: Editorial

References (30)

1. Behrns KE, Tsiotos GG, DeSouza NF, Krishna MK, Ludwig J, Nagorney DM. Hepatic steatosis as a potential risk factor for major hepatic resection. J Gastrointest Surg 1998;2:292-7.
2. Selzner M, Clavien PA. Fatty liver in liver transplantation and surgery. Semin Liver Dis 2001;21:105-13.
3. Markin RS, Wisecarver JL, Radio SJ, Stratta RJ, Langnas AN, Hirst K, et al. Frozen section evaluation of donor livers before transplantation. Transplantation 1993;56:1403-9.
4. Marsman WA, Wiesner RH, Rodriguez L, Batts KP, Porayko MK, Hay JE, et al. Use of fatty donor liver is associated with diminished early patient and graft survival. Transplantation 1996;62:1246-51.
5. Strasberg SM, Howard TK, Molmenti EP, Hertl M. Selecting the donor liver: risk factors for poor function after orthotopic liver transplantation. Hepatology 1994;20:829-38.
6. Zamboni F, Franchello A, David E, Rocca G, Ricchuti A, Lavezzo B, et al. Effect of macrovesicular steatosis and other donor and recipient characteristics on the outcome of liver transplantation. Clin Transplant 2001;15:53-7.
7. Foster KJ, Dewbury KC, Griffith AH, Whright R. The accuracy of ultrasound in the detection of fatty infiltration of the liver. Br J Radiol 1980;53:440-2.
8. Joseph AE, Saverymuttu SH, Al-Sam S, Cook MG, Maxwell JD. Comparison of liver histology with US in assessing diffuse parenchymal liver disease. Clin Radiol 1991;43:26-31.
9. Garra BS, Insana MF, Shawker TH, Russell MA. Quantitative estimation of liver attenuation and echogenicity: normal state versus diffuse liver disease. Radiology 1987;162:61-7.
10. Taylor JW, Riely CA, Hammers L, Flax F, Weltin G, Garcia-Tsao G, et al. Quantitative US attenuation in normal liver and in patients with diffuse liver disease: importance of fat. Radiology 1986;160:65-71.
11. Alpern MB, Lawson TL, Foley WD, Perlman SJ, Reif LJ, Arevalos E, et al. Focal hepatic masses and fatty infiltration detected by enhanced dynamic CT. Radiology 1986;158:45-9.
12. Bydder GM, Chapman RW, Harry D, Bassan L, Sherlock S, Kreel L. Computed tomography attenuation values in fatty liver. J Comput Tomogr 1981;5:33-5.
13. Kawata R, Sakata K, Kunieda T, Saji S, Doi H, Nozawa Y. Quantitative evaluation of fatty liver by computed tomography in rabbits. AJR 1984;142:741-6.
14. Pamilo M, Sotaniemi EA, Suramo I, Lahde S, Arranto AJ. Evaluation of liver steatotic and fibrous content by computer tomography and ultrasound. Scand J Gastroenterol 1983;18:743-7.
15. Iwasaki M, Takada Y, Hayashi M, Minamiguchi S, Haga H, Maetani Y, et al. Noninvasive evaluation of graft steatosis in living donor liver transplantation. Transplantation 2004;78:1501-5.
16. Ricci C, Longo R, Gioulis E, Bosco M, Pollessello P, Masutti F, et al. Noninvasive in vivo quantitative assessment of fat content in human liver. J Hepatol 1997;27:108-13.
17. Cheng YF, Chen CL, Lai CY, Chen TY, Huang TL, Lee TY, et al. Assessment of donor fatty livers for liver transplantation. Transplantation 2001;71:1221-5.
18. Dixon WT. Simple proton spectroscopic imaging. Radiology 1984;153:189-94.
19. Longo R, Pollesello P, Ricci C, Masutti F, Kvam BJ, Bercich L, et al. Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis. J Magn Reson Imaging 1995;5:281-5.
20. Thomsen C, Becker U, Winkler K, Christoffersen P, Jensen M, Henriksen O. Quantification of liver fat using magnetic resonance spectroscopy. Magn Reson Imaging 1994;12:487-95.
21. Thomas EL, Hamilton G, Patel N, O'Dwyer R, Doré CJ, Goldin RD, et al. Hepatic triglyceride content and its relation to body adiposity: a magnetic resonance imaging and proton magnetic resonance spectroscopy study. Gut 2005;54:122-7.
22. Fishbein M, Castro F, Cheruku S, Jain S, Webb B, Gleason T, et al. Hepatic MRI for fat quantification: its relationship to fat morphology, diagnosis, and ultrasound. J Clin Gastroenterol 2005;39:619-25.
23. Kreft BP, Tanimoto A, Baba Y, Zhao L, Chen J, Middleton MS, et al. Diagnosis of fatty liver with MR Imaging. J Magn Reson Imaging 1992;2:463-71.
24. Levenson H, Greensite F, Hoefs J, Friloux L, Applegate G, Silva E, et al. Fatty infiltration of the liver: quantification with phase-contrast MR imaging at 1.5 T vs biopsy. Am J Roentgenol 1991;156:307-12.
25. Marks SJ, Moore NR, Ryley NG, Clark ML, Pointon JJ, Strauss BJ, et al. Measurement of liver fat by MRI and its reduction by dexfenfluramine in NIDDM. Int J Obes Relat Metab Disord 1997;21:274-9.
26. Fishbein MH, Gardner KG, Potter CJ, Schmalbrock P, Smith MA. Introduction of fast MR Imaging in the assessment of hepatic steatosis. Magn Reson Imaging 1997;15:287-93.
27. Fishbein MH, Stevens WR. Rapid MRI using a modified Dixon technique: a non-invasive and effective method for detection and monitoring of fatty metamorphosis of the liver. Pediatr Radiol 2001;31:806-9.
28. Rinella ME, McCarthy R, Thakrar K, Finn JP, Rao SM, Koffron AJ. Dual-echo, chemical shift gradient-echo magnetic resonance imaging to quantify hepatic steatosis: implications for living liver donation. Liver Transpl 2003;9:851-6.
29. Pilleul F, Chave G, Dumortier J, Scoazec JY, Valette PJ. Is dual T1 gradient echo sequences on clinical MR system sensitive to detect and grade fatty infiltration of the liver? Gastroenterol Clin Biol 2005
30. Chevallier P, Longo F, Saint Paul MC, Mariné-Barjoan E, Souci J, Tran A, et al. Evaluation de la stéatose avec l'imagerie par résonance magnétique. Résultats préliminaires (résumé). Gastroenterol Clin Biol 2002;26:A91